EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Medincell's enterprise value is $543.17 Mil.
Medincell's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $11.65 Mil. Therefore, Medincell's EV-to-Revenue for today is 46.63.
The historical rank and industry rank for Medincell's EV-to-Revenue or its related term are showing as below:
MDCLF'
s EV-to-Revenue Range Over the Past 10 Years
Min: 15.78 Med: 37.7 Max: 114
Current: 46.97
During the past 8 years, the highest EV-to-Revenue of Medincell was 114.00. The lowest was 15.78. And the median was 37.70.
MDCLF's EV-to-Revenue is ranked worse than 76.97% of 1038
companies
in the Biotechnology industry
Industry Median: 7.985
vs MDCLF: 46.97
As of today (2024-06-05), Medincell's stock price is $6.9757.
Medincell's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.43. Therefore, Medincell's PS Ratio for today is 16.07.
Medincell EV-to-Revenue Historical Data
The historical data trend for Medincell's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Medincell's EV-to-Revenue
For the Biotechnology subindustry, Medincell's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medincell's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Medincell's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Medincell's EV-to-Revenue falls into.
Medincell's current Enterprise Value is $543.17 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medincell's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $11.65 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medincell's share price for today is $6.9757.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2023 was $0.43.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medincell EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Medincell's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Medincell SA is a technology-based pharmaceutical firm, aims to optimise the efficiency of medical treatments and make them accessible geographically. The company's product portfolio uses BEPO-patented technology to develop controlled, long-acting injectable medical treatments for a number of therapeutic fields. The firm has a single operating segment: ongoing research and development on processes that use biodegradable polymers to enable the controlled and prolonged release of the active principles of drugs into the human body and animals by means of injection.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MDCLF has been successfully added to your 